Sophiris Bio

Sophiris Bio: How Far Off Is Topsalysin's FDA Application?
Seeking Alpha
Tue, 10/11/16 - 09:41 am
Sophiris Bio
Topsalysin
FDA
prostate cancer
Sophiris' prostate drug stages a Phase III comeback after a grim prognosis
Fierce Biotech
Tue, 11/10/15 - 04:29 pm
Sophiris Bio
PRX302
enlarged prostate
benign prostatic hyperplasia
The Worst-Performing Biotech Stocks Of 2014
Forbes
Thu, 01/1/15 - 02:36 pm
biotech
Nymox
Elbit
PhotoMedex
Sophiris Bio
WaferGen Bio-systems
Nanosphere
Cyclacel
MELA Sciences
Cytori
Regado Biosciences
BioLife Solutions
Sophiris Bio's Lead Drug Study Looks Unpromising
Yahoo/Benzinga
Mon, 12/15/14 - 06:53 pm
Sophiris Bio
benign prostate enlargement
PRX302